Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Creative Biomolecules, Stryker extend OP-1 agreement

May 17, 1996

Estraderm MX launched in U.K.

May 10, 1996

Estring approved for marketing in U.S.

May 10, 1996

Muse safety and efficacy reported at urology meeting

May 10, 1996

Sildenafil demonstrates efficacy in erectile dysfunction Rx

May 10, 1996

AI-401 progresses to phase II

May 10, 1996

EU approval granted for Humalog

May 10, 1996

Sandoz synthesizes new antidiabetic agents

May 10, 1996

Yakult claims ACAT inhibitor from natural source

May 10, 1996

Hoechst claims bile acid sequestrants

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...